I wonder if the recent small rise in pps is in anticipation of pending FDA approval for the use of scaffolds in the 5 patient study? I also wonder if soon there after Frank Reynolds will also apply for the listing of NVIV on NASDAQ?
I wouldn't read much to anything into any price movement of late. Volume has been way too thin to read anything into price movement.
December's are always full of people re-shuffling their portfolios, selling solely for capital gain or capital loss purposes (depending on their tax situation), buying into stocks they feel will do in the upcoming year, etc.
2013 will be a GREAT year for NVIV in my opinion, but equally IMO we will not see anything worthy of mention up or down until FDA time during hopefully Q1. And most assuredly, when FDA time comes we will see very significant volume.
Voisybay, just a matter of time on approval. Ive only got a small position cause ive been waiting on other picks but im adding when i can because this is gona be huge if management acts in the patients and investors interest. Ive gotten beaten down by geron so im having to use limited funds at the moment. Steve